Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cellebrite DI Ltd.

    NASDAQ: CLBT · Real-Time Price · USD
    16.84
    0.18 (1.08%)
    At close: Jun 05, 2025, 3:59 PM
    17.12
    1.63%
    Pre-market: Jun 06, 2025, 08:24 AM EDT

    Cellebrite DI Statistics

    Share Statistics

    Cellebrite DI has 239.47M shares outstanding. The number of shares has increased by 16.65% in one year.

    Shares Outstanding

    n/a
    		 239.47M

    Shares Change (YoY)

    n/a
    		 16.65%

    Shares Change (QoQ)

    n/a
    		 15.08%

    Owned by Institutions (%)

    n/a
    		 52.49%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 37

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.81M, so 0.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.81M

    Short % of Shares Out

    n/a
    		 0.75%

    Short % of Float

    n/a
    		 1.56%

    Short Ratio (days to cover)

    n/a
    		 1.27

    Valuation Ratios

    The PE ratio is -16.31 and the forward PE ratio is 42.65. Cellebrite DI's PEG ratio is -0.08.

    PE Ratio

    n/a
    		 -16.31

    Forward PE

    n/a
    		 42.65

    PS Ratio

    n/a
    		 11.5

    Forward PS

    n/a
    		 5.7

    PB Ratio

    n/a
    		 13.73

    P/FCF Ratio

    n/a
    		 37.96

    PEG Ratio

    n/a
    		 -0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cellebrite DI.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 1.92

    Quick Ratio

    n/a
    		 1.89

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 0.16

    Debt / FCF

    n/a
    		 0.09

    Interest Coverage

    n/a
    		 0.16

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $343,790.06

    Profits Per Employee

    n/a
    		 $-242,508.14

    Employee Count

    n/a
    		 1,167

    Asset Turnover

    n/a
    		 0.58

    Inventory Turnover

    n/a
    		 7

    Taxes

    Income Tax

    n/a
    		 7.02M

    Effective Tax Rate

    n/a
    		 -2.54%

    Stock Price Statistics

    The stock price has increased by 59.62% in the last 52 weeks. The beta is 1.32, so Cellebrite DI's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.32

    52-Week Price Change

    n/a
    		 59.62%

    50-Day Moving Average

    n/a
    		 18.53

    200-Day Moving Average

    n/a
    		 19.26

    Relative Strength Index (RSI)

    n/a
    		 39.13

    Average Volume (20 Days)

    n/a
    		 1,412,994

    Income Statement

    In the last 12 months, Cellebrite DI had revenue of 401.2M and earned -283.01M in profits. Earnings per share was -1.35.

    Revenue

    n/a
    		 401.2M

    Gross Profit

    n/a
    		 338.61M

    Operating Income

    n/a
    		 56.91M

    Net Income

    n/a
    		 -283.01M

    EBITDA

    n/a
    		 67.51M

    EBIT

    n/a
    		 -274.38M

    Earnings Per Share (EPS)

    n/a
    		 -1.35
    Full Income Statement

    Balance Sheet

    The company has 191.66M in cash and 10.97M in debt, giving a net cash position of 180.69M.

    Cash & Cash Equivalents

    n/a
    		 191.66M

    Total Debt

    n/a
    		 10.97M

    Net Cash

    n/a
    		 180.69M

    Retained Earnings

    n/a
    		 -164.86M

    Total Assets

    n/a
    		 690.57M

    Working Capital

    n/a
    		 272.09M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 132.17M and capital expenditures -10.61M, giving a free cash flow of 121.56M.

    Operating Cash Flow

    n/a
    		 132.17M

    Capital Expenditures

    n/a
    		 -10.61M

    Free Cash Flow

    n/a
    		 121.56M

    FCF Per Share

    n/a
    		 0.58
    Full Cash Flow Statement

    Margins

    Gross margin is 84.4%, with operating and profit margins of 14.18% and -70.54%.

    Gross Margin

    n/a
    		 84.4%

    Operating Margin

    n/a
    		 14.18%

    Pretax Margin

    n/a
    		 -68.79%

    Profit Margin

    n/a
    		 -70.54%

    EBITDA Margin

    n/a
    		 16.83%

    EBIT Margin

    n/a
    		 14.18%

    FCF Margin

    n/a
    		 30.3%

    Dividends & Yields

    CLBT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLBT is $24, which is 42.5% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $24

    Price Target Difference

    n/a
    		 42.5%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.87

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist